NK cells complexed with bispecific antibody yield high response rates in patients with lymphoma

NK cells complexed with bispecific antibody yield high response rates in patients with lymphoma

MD Anderson

Phase I trial demonstrates AFM13-NK cells are safe and highly effective in heavily pretreated patients HOUSTON ― A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe […]

Contact The Katy News

Have a news tip, story idea, advertising question, or community announcement?

The Katy News
Serving Katy and the surrounding communities

General Inquiries: info@thekatynews.com
Advertising: ads@thekatynews.com
Article Submissions: articles@thekatynews.com

Phone: 281-396-3333

Follow Us

Copyright © The Katy News

Business Directory Add Listing